Wörmann BJ - Search Results

1

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.

Hartmann L, Dutta S, Opatz S, Vosberg S, Reiter K, Leubolt G, Metzeler KH, Herold T, Bamopoulos SA, Bräundl K, Zellmeier E, Ksienzyk B, Konstandin NP, Schneider S, Hopfner KP, Graf A, Krebs S, Blum H, Middeke JM, Stölzel F, Thiede C, Wolf S, Bohlander SK, Preiss C, Chen-Wichmann L, Wichmann C, Sauerland MC, Büchner T, Berdel WE, Wörmann BJ, Braess J, Hiddemann W, Spiekermann K, Greif PA. Hartmann L, et al. Among authors: wormann bj. Nat Commun. 2016 Jun 2;7:11733. doi: 10.1038/ncomms11733. Nat Commun. 2016. PMID: 27252013 Free PMC article.

2

Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.

Hiddemann W, Schleyer E, Unterhalt M, Zühlsdorf M, Rolf C, Reuter C, Kewer U, Uhrmeister C, Wörmann B, Büchner T. Hiddemann W, et al. Leukemia. 1992 Dec;6(12):1273-80. Leukemia. 1992. PMID: 1453772

3

GM-CSF in the treatment of acute myeloid leukemia.

Hiddemann W, Maschmeyer G, Ludwig WD, Königsmann M, Zühlsdorf M, Wörmann B, Boeckmann A, Agion-Freire E, Innig G, Reuter C, et al. Hiddemann W, et al. Pathol Biol (Paris). 1992 Nov;39(9):959. Pathol Biol (Paris). 1992. PMID: 1538952 No abstract available.

4

Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.

Terstappen LW, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B. Terstappen LW, et al. Leukemia. 1992 Jan;6(1):70-80. Leukemia. 1992. PMID: 1540262

5

Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.

Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T. Hiddemann W, et al. Semin Oncol. 1992 Apr;19(2 Suppl 4):31-7. Semin Oncol. 1992. PMID: 1553573

6

Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.

Büchner T, Hiddemann W, Wörmann B, Löffler H, Maschmeyer G, Hossfeld D, Ludwig WD, Nowrousian M, Aul C, Schaefer UW, et al. Büchner T, et al. Leukemia. 1992;6 Suppl 2:68-71. Leukemia. 1992. PMID: 1578946 Clinical Trial.

7

Analysis of the cellular DNA and RNA content in acute leukemias by flow cytometry.

Hiddemann W, Wörmann B, Messerer D, Springefeld R, Büchner T. Hiddemann W, et al. J Cancer Res Clin Oncol. 1990;116(5):507-12. doi: 10.1007/BF01613003. J Cancer Res Clin Oncol. 1990. PMID: 1699947

8

Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.

Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J. Hiddemann W, et al. Ann Hematol. 1991 Jul;63(1):1-4. doi: 10.1007/BF01714952. Ann Hematol. 1991. PMID: 1715191

9

In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).

Wörmann B, Hiddemann W, Frisch J, Zühlsdorf M, Rottmann R, Boeckmann A, Reuter C, Freire EA, Innig G, Schulz G, et al. Wörmann B, et al. Behring Inst Mitt. 1991 Dec;(90):28-38. Behring Inst Mitt. 1991. PMID: 1801688 Clinical Trial.

10

Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.

Büchner T, Hiddemann W, Koenigsmann M, Zühlsdorf M, Wörmann B, Boeckmann A, Freire EA, Innig G, Maschmeyer G, Ludwig WD, et al. Büchner T, et al. Blood. 1991 Sep 1;78(5):1190-7. Blood. 1991. PMID: 1878586 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters